Global Private Equity Firms Eye Stake in IndiaRF's Synthimed Labs for $150-200 Million
Global Private Equity Firms Eye Minority Stake in Synthimed Labs
Synthimed Labs Pvt. Ltd (SLPL), a pharmaceutical ingredients maker backed by India Resurgence Fund, is reportedly being evaluated by a group of global private equity firms for a minority stake investment. The firms in question include General Atlantic, KKR, and CVC Capital Partners, among others.
According to sources, this potential investment is in preparation for SLPL's upcoming public listing. The involvement of these prominent private equity firms suggests a strong interest in SLPL's growth prospects and potential for future expansion.
Key Figures:
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
- General Atlantic: Global private equity firm
- KKR: Global private equity firm
- CVC Capital Partners: Global private equity firm
- India Resurgence Fund: Backer of Synthimed Labs Pvt. Ltd (SLPL)
Investor Takeaway
Investors should be aware of potential opportunities in the Indian pharma sector.
More in Market
Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
Indian Stocks to Watch: BHEL, Agarwal Industrial, JBM Auto, Rajesh Exports, Indian Energy Exchange, Lenskart Solutions in Market Focus on June 4.
